Fortitude Family Office’s IDEAYA Biosciences IDYA Stock Holding History

Fortitude Family Office’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49K	Buy	40 +14	+54%	+$429	﹤0.01%	1601
2026 Q1	$866	Hold	26	–	–	﹤0.01%	1547
2025 Q4	$899	Hold	26	–	–	﹤0.01%	1502
2025 Q3	$707	Hold	26	–	–	﹤0.01%	1670
2025 Q2	$547	Buy	+26	New	+$499	﹤0.01%	1756
2024 Q4	–	Sell	-5	Closed	-$158	–	1342
2024 Q3	$158	Hold	5	–	–	﹤0.01%	1192
2024 Q2	$176	Hold	5	–	–	﹤0.01%	943
2024 Q1	$219	Hold	5	–	–	﹤0.01%	951
2023 Q4	$178	Buy	+5	New	+$149	﹤0.01%	994

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Fortitude Family Office's IDYA Position: Q2 2026 in Review

Fortitude Family Office increased its IDEAYA Biosciences (IDYA) stake by 54% in Q2 2026, buying an estimated $429 and bringing the position to 40 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1601.

Fortitude Family Office first reported a position in IDYA in Q4 2023 and has held it in 9 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

Fortitude Family Office held 40 shares of IDEAYA Biosciences worth $1.49K as of Q2 2026.
Fortitude Family Office bought 14 IDEAYA Biosciences shares in Q2 2026, an estimated $429.
IDEAYA Biosciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1601 holding.
Fortitude Family Office first reported a position in IDEAYA Biosciences in Q4 2023 and has held it in 9 quarters since.
285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.